Metronidazole appears not to be a human teratogen: Review of literature

Infectious Diseases in Obstetrics and Gynecology

Volumn 5, Issue 5, 1997, Pages 326-335

  Struthers, Barbara J ^a  

^a PFIZER INC   (United States)

Author keywords

Bacterial vaginosis; Metronidazole; Pregnancy; Premature rupture of membranes; Preterm birth; Teratogenicity; Trichomoniasis

Indexed keywords

METRONIDAZOLE;

CONFERENCE PAPER; DRUG SAFETY; DRUG USE; HUMAN; LOW BIRTH WEIGHT; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; TERATOGENESIS; TRICHOMONIASIS; VAGINITIS;

EID: 0031421450     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-0997(1997)5:5<326::aid-idog4>3.3.co;2-8     Document Type: Conference Paper

References (68)

1. Rustia M, Shubik P: Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst 48:721-729, 1972.
2. Rustia M, Shubik P: Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC(WI)BR rats. J Natl Cancer Inst 63:863-868, 1979.
3. Heisterberg L: Placental transfer of metronidazole in the first trimester of pregnancy. J Perinatol Med 12:43-45, 1984.
4. Amon I, Amon K: Placental transfer and fetal distribution of metronidazole in early human pregnancy. Int J Biol Res Pregnancy 1:61-64, 1980.
5. Rosa FW, Baum C, Shaw M: Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol 69:751-755, 1987.
6. Morgan I: Metronidazole treatment in pregnancy. Int J Gynecol Obstet 15:501-502, 1978.
7. Heinonen OP, Slone D, Shapiro S: Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group, pp. 296-303, 1977.
8. Piper JM, Mitchell DF, Ray WA: Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 82:348-352, 1993.
9. Hauth JC, Goldenberg RL, Andrews WW, et al.: Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333:1732-1736, 1995.
10. Morales WJ, Schorr S, Albritton J: Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 171:345-349, 1994.
11. Scott-Gray M: Metronidazole in obstetric practice. J Obstet Gynecol Br Comm 71:82-85, 1964.
12. Peterson WF, Stauch JE, Ryder CD: Metronidazole in pregnancy. Am J Obstel Gynecol 94:343-349, 1966.
13. Magnin P, Ambrose-Thomas P, Thoulon JM, Laurent HM: Traitement par le metronidazole de la vaginite a trichomonas de la femme enceinte. Absence d'effets teratogenes. Rev Franc Gyn Obstet 61:861-867, 1966.
14. Perl G: Metronidazole treatment of trichomoniasis in pregnancy. Obstet Gynecol 25:273-276, 1965.
15. Pagnozzi A, Pavetto PF, Malanetto C: Terapia trichomonicida in gravidanza. Minerva Gineco 21:857-860, 1969.
16. Sands RX: Pregnancy, trichomoniasis, and metronidazole. Am J Obstet Gynecol 94:35-33, 1966.
17. Watt L, Jennison RF: Metronidazole treatment of trichomoniasis in the female: Report of an extended trial. Br Med J 1:276-279, 1962.
18. Zacharias LF, Salzer RB, Gunn JC, Dierkscheide EB: Trichomoniasis and metronidazole. Am J Obstet Gynecol 86:748-752, 1963.
19. Williams BFP: Metronidazole in the treatment of trichomonal infections. Obstet Gynecol 20:611-614, 1962.
20. Parker RT, Thomas WT, Jones CP: Metronidazole in the treatment of vaginal trichomoniasis: hematologic, neurologic, and long-term clinical evaluations. Southern Med J 58:211-214, 1965.
21. Kotcher E, Frick CA, Griesel IO: The effect of metronidazole on vaginal microbiology and maternal and neonatal hematology. Am J Obstet Gynecol 88:184-189, 1964.
22. Robinson SC, Mirchandi G: Trichomonas vaginalis. Further observations on metronidazole (Flagyl) (including infant follow-up). Am J Obstet Gynecol 93:502-505, 1965.
23. Berget A, Weber T: Metronidazol og graviditet. Ugeskrift Laeger 134:2085-2089, 1972.
24. Nigam P, Kapoor KK, Kumar K, et al.: Hepatic abscess during pregnancy. Clinician 145-151, 1988.
25. Beard CM: Cancer after metronidazole. N Engl J Med 2:520, 1980.
26. Scott-Gray M: Trichomonas vaginalis in pregnancy. The results of metronidazole therapy on the mother and child. J Obstet Gynecol 8:723-729, 1961.
27. Schram M, Kleinman H: Use of metronidazole in the treatment of trichomoniasis. Am J Obstet Gynecol 83: 1284-1287, 1962.
28. Lyon FA, Sinykin MB, Maxwell MB: Trichomonal vaginitis treated with metronidazole. Am J Obstet Gynecol 85:955-958, 1963.
29. Andrews MC, Andrews WC: Systemic treatment of trichomonas vaginitis. Southern Med J 56:1214-1217, 1963.
30. Cantú JM, Garcia-Cruz D: Midline facial defect as a teratogenic effect of metronidazole. Birth Defects 18: 85-88, 1982.
31. Pereyra AJ, Lansing JR: Urogenital trichomoniasis. Treatment with metronidazole in 2002 incarcerated women. Obstet Gynecol 24:499-508, 1964.
32. Glowinski M, Chrusciel A: La trichomonase de la femme enceinte et son traitement par le 8828 R P. Gynecol Prat 15:239-246, 1964.
33. Gardner HL, Dukes CD: Clinical and laboratory effects of metronidazole. Am J Obstet Gynecol 89:990-995, 1964.
34. Whitelaw MJ, Fox LP, Schlichting FR: Results of treatment of trichomoniasis with metronidazole (Flagyl) in private and clinic patients. Western J Surg Obstet Gynecol 72:232-233, 1963.
35. Rodin P, Hass G: Metronidazole and pregnancy. Br J Vener Dis 42:210-212, 1966.
36. Csonka GW: Long-term aspect of treatment with metronidazole (Flagyl) in Trichomonas vaginalis. Br J Vener Dis 39:258-260, 1963.
37. Monroe SE: Trichomoniasis: clinical trial of Metronidazole (Flagyl). California Med 98:256-259, 1963.
38. Doyle JC, Rolf BB. Treatment of trichomoniasis with metronidazole. Obstet Gynecol 24:130-134, 1964.
39. Ross SM, Van Middlekoop A: Trichomonas infection in pregnancy - does it affect perinatal outcome? African Med J 63:566-567, 1983.
40. Carvajal A, Sanchez A, Hurtarte G: Metronidazole during pregnancy (letter). Int J Gynecol Obstet 48:323-324, 1995.
41. Perl C, Ragnozzi H: Flagyl in treatment of Trichomonas vaginalis vaginitis. Obstet Gynecol 19:595-597, 1962.
42. Robinson SC, Johnston DW: Observations on vaginal trichomoniasis in treatment with metronidazole. Can Med Assn J 85:1094-1096, 1961.
43. Doyle JC, Rolf, BB: Treatment of trichomoniasis with metronidazole. Obstet Gynecol 24:130-134, 1964.
44. Burtin P, Taddio A, Arinburnuo, et al.: Safety of metronidazole in pregnancy: A meta-analysis. Am J Obstet Gynecol 172:525-529, 1995.
45. Schardein JL: Chemically Induced Birth Defects. 2nd ed. New York: Marcel Dekkor, 1993.
46. Accutane® (Isotretinoin) detailed product information. Roche Laboratories, Inc. Nutley, NJ: vii:370-371.
47. Achromycin® (Tetracycline HCl) detailed product information. Lederle Laboratories Division, American Cyanamid Co. Pearl River, NY.
48. Bost RG: Metronidazole: toxicology and teratology. In: Finegold SM (ed.): Metronidazole Proceedings. Montreal, May 26-28, 1976. Amsterdam: International Congress Series No. 438, Excerpta Medica pp 112-118, 1977.
49. Cella PL: Ricerche sperimentali sulla teratologia del metronidazolo. Riv Patol Clin 24:529-537, 1969.
50. Chacko M, Bhide SV: Carcinogenicity, perinatal carcinogenicity and teratogenicity of low dose metronidazole (MNZ) in Swiss mice. J Cancer Res Clin Oncol 112: 135-140, 1986.
51. Ivanov I: The effect of "trichomonacide" on pregnancy in experimental animals. Akush Ginekol 8:241-244, 1969.
52. Giknis MLA, Dajanov I: The transplacental effects of ethanol and metronidazole in Swiss Webster mice. Toxicol Lett 19:37-42, 1983.
53. NIOSH Registry of toxic effects of chemical substances, 1983-84 suppl, K06300000, ethyl alcohol, p. 893.
54. Trussell R: Trichomonas vaginalis & Trichomoniasis. Springfield, IL: Charles C. Thomas Publishers, 1947.
55. Minkoff H: Risk factors for prematurity and premature rupture of membranes: A prospective study of vaginal flora in pregnancy. Am J Obstet Gynecol 150:965-972, 1984.
56. Minkoff H, Grunebaum AN, Schwarz RH, et al.: Prematurity: infection as an etiologic factor. Obstet Gynecol 62:137, 1983.
57. Hardy PH, Nell EE, Spence MR, et al.: Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet 2:333-337, 1984.
58. Keith LG, Freiberg J, Fullan N, et al.: The possible role of Trichomonas vaginalis as a vector for the spread of other pathogens. Int J Fertil 31:272-277, 1986.
59. Martius J, Krohn MA, Hillier SL, et al.: Relationship of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 71:89-95, 1988.
60. Gravett MG, Nelson HP, Deroven T, et al.: Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 256:1899-1903, 1986.
61. Kurki T, et al.: Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 80:173-177, 1992.
62. Hillier SL, Martius J, Krohn MA, et al.: A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 319:972-978, 1988.
63. Gravett MG, Hummel D, Eschenbach DA, Holmes KK: Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 67:229-237, 1986.
64. Watts DH, Krohn MA, Hillier SL, Eschenbach DH: Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol 75:52-58, 1990.
65. Rosene K, Eschenbach DA, Tompkins LS, Kenney GE, Watkins H: Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis 153:1028-1037, 1986.
66. Hillier SL, Nugent RP, Eschenbach DA, et al.: Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 333:1737-1742, 1995.
67. Cotch MF, Pastorek JG II, Nugent RP, et al.: Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Trans Dis 24:353-360, 1997.
68. Hook EB: Human teratogenic and mutagenic masters in monitoring about point source of pollution. Environ Res 25:178-203, 1981.